Sub-Classification of Triple-Negative Breast Cancer using Androgen Receptor and Cytokeratin 5/6
Leonard Derkyi-Kwarteng, L. Ahenkorah Fondjo, P. Kafui Akakpo, Eric Aidoo, Ato Brown, Ellen Ola, Stephanie K. A. Adjei & Francis Agyemang · Journal of Cancer and Tumor International · 2022
Background: Triple negative breast cancer (TNBC) is a unique heterogenous subtypes of breast cancer which is characterized by negative estrogen, progesterone, and human epidermal growth factor receptor (HER-2) status. TNBC displays different molecular phenotype with which basal-...
Open access
Research Article
10.9734/jcti/2022/v12i330181